Genelux Corporation Common Stock

Go to Genelux Corporation Common Stock Website

$3.83

(%)
Live
Previous Close

$3.83

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$102.9 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products includ...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Genelux Corporation (GNLX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Related tickers: GNLX.

Read Full Article

The heavy selling pressure might have exhausted for Genelux Corporation (GNLX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Related tickers: GNLX.

Read Full Article
Trending Tickers
LASE

XNAS

$2.04
(%)
PACW

XNAS

$7.54
(%)
SMFL

XNAS

$3.58
(%)
SQ

XNYS

$69.47
(%)
MLGO

XNAS

$0.00
(%)